fda warning letter compounding semaglutide october 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Compounding of GLP-1 Drugs |
Description
For simplicity, we use the general expression K level in this document
Compounding pharmacies may use different salts or additives that can alter the medication's efficacy and safety profile
Second, increased energy expenditure burns more calories at rest
Due to the lack of targeted research, its not possible to definitively determine whether GLP-1 drugs are completely safe or unsafe for those with hemophilia
Use reliable contraception if pregnancy is not desired
